Trademark: 90563497
Status Date
Friday, December 15, 2023
Filing Date
Friday, March 5, 2021
Published for Opposition
Tuesday, November 9, 2021
5 Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer
44 Medical services; Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; Medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders
42 Medical research and development; Research and development of pharmaceuticals; Research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Molecular, cellular, and genetic research and development; Development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders
Dec 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 15, 2023
Sou Extension 4 Granted
Dec 15, 2023
Sou Extension 4 Filed
Dec 15, 2023
Sou Teas Extension Received
Jun 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 26, 2023
Sou Extension 3 Granted
Jun 26, 2023
Sou Extension 3 Filed
Jun 26, 2023
Sou Teas Extension Received
Jan 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2023
Sou Extension 2 Granted
Jan 3, 2023
Sou Extension 2 Filed
Jan 3, 2023
Sou Teas Extension Received
Jul 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2022
Sou Extension 1 Granted
Jul 5, 2022
Sou Extension 1 Filed
Jul 5, 2022
Sou Teas Extension Received
Jan 4, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 5, 2021
Teas Change Of Correspondence Received
Oct 5, 2021
Teas Change Of Owner Address Received
Oct 4, 2021
Approved For Pub - Principal Register
Oct 4, 2021
Teas/Email Correspondence Entered
Oct 4, 2021
Correspondence Received In Law Office
Oct 4, 2021
Teas Response To Office Action Received
Sep 30, 2021
Notification Of Non-Final Action E-Mailed
Sep 30, 2021
Non-Final Action E-Mailed
Sep 30, 2021
Non-Final Action Written
Sep 27, 2021
Assigned To Examiner
Sep 3, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 3, 2021
Teas Change Of Correspondence Received
Sep 3, 2021
Teas Change Of Owner Address Received
Jun 5, 2021
New Application Office Supplied Data Entered
Mar 9, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
